References
- Lindberg B. S., Sandstrom B. “How Swedish obstetricians manage hypertension in pregnancy”. Acta Obstet. Gynecol. Scand. 1981; 60: 327
- Rubin P. C. “Beta-Blockers in Pregnancy”. New Engl. J. Med. 1981; 302: 1323
- Sandstrom B. “Antihypertensive treatment with the Adrenergic Beta-Receptor Blocker Metoprolol during Pregnancy”. Gynecol. Obstet. Invest. 1978; 9: 193
- Melander A., Niklasson B., Ingemarsson I., Liedholm H., Schersten P., Sjoberg N-O. “Transplacental Passage of Ate-in Man”. Eur. J. Clin. Pharmacol. 1978; 14: 93
- Rochard F., Schifrin B. S., Goupil F., Legrand H., Blottiere J., Sureau C. “Nonstressed fetal heart rate monitoring in the antepartum period”. Am. J. Obstet. Gynecol. 1976; 126: 699
- Visser G. H.A., Huisjes H. J. “Diagnostic value of the unstressed antepartum cardiotocogram”. Br. J. Obst. & Gyn. 1977; 84: 321
- Evertson L. R., Paul R. H. “Antepartum fetal heart rate testing: The nonstress test”. Am. J. Obstet. Gynecol. 1978; 132: 895
- Flynn A. M., Kelly J. “Evaluation of fetal wellbeing by antepartum fetal heart monitoring”. Br. Med. J. 1977; 936
- Fischer W. M., Kardiotokographie G. Thieme Verlag, Stuttgart 1973; 115
- Wichman K., Ryden G., Karlberg B. E. “Metoprolol in the treatment of mild to moderate hypertension in pregnancy - effects on the mother”. Clin, and exper. hyper.-Hyper.in pregnancy 1985; B4(2&3)141
- Sadovsky E., Yaffe H. “Daily fetal movement recording and fetal prognosis”. Obstet. Gynecol. 1973; 41: 845
- Ehrstrom C. “Fetal movement monitoring in normal and high risk pregnancy”. Acta Obstet. Gynecol. Scand. 1979, Suppl. 80
- Ingemarsson I., Tiedholm H., Montan S., Wetsgren M., Melander A. “Fetal heart rate during treatment of maternal hypertension with beta-adrenergic antagonists”. A preliminary report. Acta Obstet. Gynecol. Scand. 1984; 95(Suppl. 118)
- Montan S., Solum T., Sjoberg N-O. “Influence of the beta-1-adrenoceptors blocker atenolol on antenatal cardiotocography”. Acta Obstet. Gynecol. 1984; 118: 99
- Rubin P. C., et al. “Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoceptor antagonist atenolol”. Am. J. Obstet. Gynecol. 1984; 150: 389
- Rubin A. C., Butters I., Clark D. M., et al. “Placebo controlled trial of atenolol in the treatment of pregnancy associated hypertension”. Lancet 1983; i: 431
- Thorley K. J., McAinsh J., Cruickshank J. M. “Atenolol in the treatment of pregnancy-induced hypertension”. Br. J. clin. Pharmac 1981; 12: 725
- Käär K. “Antepartal cardiotocography in the assessment of fetal outcome”. Acta Obstet. Gynecol. Scand. Suppl. 1980; 94: 14
- Högstedt S., Lindberg B., Lindeberg S., Ludviksson K., Sandström B. Abstract. 4th World Congress of the International Society for the study of hypertension in pregnancy, Amsterdam, 1984